Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06896084 · ClinicalTrials.gov registry record

Comparison of Surgeons' Object Discernment Via Their Hands Versus Using a Robotic Surgical System That Does Not Incorporate Haptics

A clinical trial, sponsored by Valley Health System.

Completed
Registry status
53
Enrollment target

NCT06896084: Completed study, sponsored by Valley Health System.

NCT06896084 is a clinical trial that has completed, run by Valley Health System. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06896084 has completed, sponsored by Valley Health System.

COMPLETED
Registry status
53 participants
Enrollment target

Study Summary

The purpose of this study is to compare surgeons' discernment of 4 balloons filled with different materials when using their eyes and hands versus using the da Vinci robot.

Primary Outcome

Using the Farrington-Manning test of binary non-inferiority, investigators hypothesize that 100% correct balloon discernment by hands-on surgeons and prospectively set 80% correct discernment by robotic surgeons as their definition of non-inferiority. A correct response is a binary outcome for each of the four balloons.

Interventions

  • DEVICE da Vinci Xi System

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2023-08-31
Est. Completion 2024-08-09
Valley Health System

8 total trials

What the finished NCT06896084 record still lists

NCT06896084 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which da Vinci Xi System is the first listed.

NCT06896084 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06896084 about?

NCT06896084 is a clinical study titled "Comparison of Surgeons' Object Discernment Via Their Hands Versus Using a Robotic Surgical System That Does Not Incorporate Haptics". The purpose of this study is to compare surgeons' discernment of 4 balloons filled with different materials when using their eyes and hands versus using the da Vinci robot.

What is the current status of trial NCT06896084?

This trial is currently completed. The enrollment target is 53 participants. The study started on 2023-08-31. Estimated completion is 2024-08-09.

What interventions are being tested in trial NCT06896084?

The interventions under investigation include: da Vinci Xi System (DEVICE).

Who is sponsoring clinical trial NCT06896084?

This trial is sponsored by Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06896084, the US trial registry maintained by the National Library of Medicine. NCT06896084 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.